Neuronetics Stock Price on June 21, 2024
| STIM Stock | USD 1.39 0.10 7.75% |
Below is the normalized historical share price chart for Neuronetics extending back to June 28, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neuronetics stands at 1.39, as last reported on the 21st of December, with the highest price reaching 1.42 and the lowest price hitting 1.26 during the day.
If you're considering investing in Neuronetics Stock, it is important to understand the factors that can impact its price. Neuronetics is dangerous given 3 months investment horizon. Neuronetics has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.08% are justified by taking the suggested risk. Use Neuronetics Mean Deviation of 5.52, downside deviation of 9.22, and Risk Adjusted Performance of 0.0993 to evaluate company specific risk that cannot be diversified away.
Neuronetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of June 2018 | 200 Day MA 1.9534 | 50 Day MA 1.0126 | Beta 2.216 |
Neuronetics |
Sharpe Ratio = 0.1304
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | STIM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.29 actual daily | 73 73% of assets are less volatile |
Expected Return
| 1.08 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Neuronetics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuronetics by adding it to a well-diversified portfolio.
Price Book 8.2456 | Enterprise Value Ebitda (2.02) | Price Sales 1.2537 | Shares Float 24.1 M | Wall Street Target Price 2.6667 |
Neuronetics Main Headline on 21st of June 2024
Disposition of 5813 shares by Furlong Stephen of Neuronetics... by Furlong Stephen
Filed transaction by Neuronetics Officer Evp, Cfo And Treasurer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Neuronetics Valuation on June 21, 2024
It is possible to determine the worth of Neuronetics on a given historical date. On June 21, 2024 Neuronetics was worth 1.85 at the beginning of the trading date compared to the closed value of 1.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neuronetics stock. Still, in general, we apply an absolute valuation method to find Neuronetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuronetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neuronetics' related companies.
| Open | High | Low | Close | Volume | |
| 1.83 | 1.89 | 1.77 | 1.79 | 78,150 | |
06/21/2024 | 1.85 | 1.92 | 1.80 | 1.83 | 109,605 |
| 1.81 | 1.87 | 1.73 | 1.77 | 169,899 |
| Backtest Neuronetics | | | Neuronetics History | | | Neuronetics Valuation | Previous | Next |
Neuronetics Trading Date Momentum on June 21, 2024
| On June 24 2024 Neuronetics was traded for 1.77 at the closing time. The top price for the day was 1.87 and the lowest listed price was 1.73 . The trading volume for the day was 169.9 K. The trading history from June 24, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.28% . The trading delta at closing time against the current closing price is 0.55% . |
Neuronetics Fundamentals Correlations and Trends
By evaluating Neuronetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neuronetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neuronetics Stock history
Neuronetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuronetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuronetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuronetics stock prices may prove useful in developing a viable investing in Neuronetics
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Neuronetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 198 people.
Neuronetics Quarterly Net Working Capital |
|
Neuronetics Stock Technical Analysis
Neuronetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Neuronetics Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Neuronetics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neuronetics December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Neuronetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuronetics shares will generate the highest return on investment. By undertsting and applying Neuronetics stock market strength indicators, traders can identify Neuronetics entry and exit signals to maximize returns
Neuronetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuronetics' price direction in advance. Along with the technical and fundamental analysis of Neuronetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuronetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0993 | |||
| Jensen Alpha | 0.8822 | |||
| Total Risk Alpha | 0.6952 | |||
| Sortino Ratio | 0.0979 | |||
| Treynor Ratio | 0.4795 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.